Sign In
Buy PBH
$50.22
+0.270 (+0.541%)
At Close: Jul 31, 2026
PBH Q3 Earnings Beat Estimates, EPS View Raised, Shares Gain 14.8%
10:25am, Friday, 07'th Feb 2025
Prestige Consumer Healthcare witnesses continued international growth in the third quarter, banking on strong sales of the Hydralyte brand.
Prestige Consumer Healthcare Inc. (PBH) Q3 2025 Earnings Call Transcript
11:02am, Thursday, 06'th Feb 2025
Prestige Consumer Healthcare Inc. (NYSE:PBH ) Q3 2025 Results Conference Call February 6, 2025 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations Ron Lombardi - Chair
Prestige Consumer Healthcare (PBH) Q3 Earnings and Revenues Beat Estimates
08:11am, Thursday, 06'th Feb 2025
Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.06 per share a year ago
Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook
06:00am, Thursday, 06'th Feb 2025
TARRYTOWN, N.Y., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and first nine months ended December 31, 2024.
PBH vs. BSX: Which Stock Is the Better Value Option?
12:41pm, Friday, 31'st Jan 2025
Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents invest
Prestige Consumer Stock Up 29.9% in a Year: What's Behind the Surge?
09:25am, Wednesday, 22'nd Jan 2025
PBH sees remarkable gains from long-term brand-building strategies and developing the e-commerce channel.
PBH or BSX: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 15'th Jan 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two stocks offers va
PBH vs. BSX: Which Stock Is the Better Value Option?
12:41pm, Monday, 30'th Dec 2024
Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents invest
5 Beaten-Down MedTech Stocks Set to Rebound in 2025
09:25am, Monday, 30'th Dec 2024
Investors may want to take a closer look at discounted stocks, such as MCK, HAE, ARAY, LIVN and PBH, in the present market landscape.
Should Prestige Consumer Stock Stay in Your Portfolio Right Now?
08:01am, Thursday, 26'th Dec 2024
Investors remain optimistic about PBH stock due to its strong focus on brand building.
PBH or ABT: Which Is the Better Value Stock Right Now?
12:42pm, Friday, 13'th Dec 2024
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks presents investors with the bett
Premium Brands Holdings: Serving Up Protein On Both Sides Of The Border
11:24am, Friday, 06'th Dec 2024
Premium Brands Holdings has expanded from Western Canada to the US, focusing on specialty foods and wholesale distribution through acquisitions. PBH aims for $10B annual revenue by 2027, leveraging a
PBH or SYK: Which Is the Better Value Stock Right Now?
12:46pm, Wednesday, 27'th Nov 2024
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
PBH vs. SYK: Which Stock Is the Better Value Option?
12:45pm, Monday, 11'th Nov 2024
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks is more attractive to value inv
Prestige Consumer Healthcare Inc (PBH) Q2 2025 Earnings Call Transcript
11:50am, Saturday, 09'th Nov 2024
Prestige Consumer Healthcare Inc (NYSE:PBH ) Q2 2025 Results Conference Call November 7, 2024 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations Ron Lombardi - Chairm
